butyric acid

butyric acid is a lipid of Fatty Acyls (FA) class. Butyric acid is associated with abnormalities such as PARKINSON DISEASE, LATE-ONSET, Colitis, Autoimmune Diseases, Inflammatory Bowel Diseases and PARAGANGLIOMAS 2. The involved functions are known as DNA Methylation, Transcription, Genetic, chromatin modification, Gene Expression and Gene Silencing. Butyric acid often locates in Membrane, Chromatin Structure, Chromosomes, viral nucleocapsid location and Ribosomes. The associated genes with butyric acid are Locus, Genes, Dominant, Genes, rRNA, Genome and Chromatin. The related lipids are Butyrates, butyrate, Promega, Butyric Acids and Butyric Acid.

Cross Reference

Introduction

To understand associated biological information of butyric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with butyric acid?

butyric acid is suspected in Colitis, Ulcerative Colitis, Anemia, Sickle Cell, Thalassemia, PARKINSON DISEASE, LATE-ONSET, Infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with butyric acid

MeSH term MeSH ID Detail
Acidosis D000138 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenoma D000236 40 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anaplasia D000708 1 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Aphakia, Postcataract D001036 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Astigmatism D001251 1 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Sarcoma, Avian D001357 2 associated lipids
Body Weight D001835 333 associated lipids
Brain Diseases D001927 27 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Burns D002056 34 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Cattle Diseases D002418 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Constipation D003248 8 associated lipids
Corneal Diseases D003316 13 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Dental Leakage D003763 5 associated lipids
Dentin, Secondary D003809 2 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diarrhea D003967 32 associated lipids
Disease Models, Animal D004195 4 associated lipids
Diverticulitis D004238 1 associated lipids
Diverticulitis, Colonic D004239 1 associated lipids
Dysentery D004403 4 associated lipids
Edema D004487 152 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Facial Injuries D005151 1 associated lipids
Fatty Liver D005234 48 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Glioma D005910 112 associated lipids
Glycogen Storage Disease Type II D006009 2 associated lipids
Granuloma, Lethal Midline D006103 2 associated lipids
Hemolysis D006461 131 associated lipids
Hemorrhoids D006484 2 associated lipids
Per page 10 20 50 100 | Total 149

PubChem Associated disorders and diseases

What pathways are associated with butyric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with butyric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with butyric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with butyric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with butyric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with butyric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with butyric acid

Download all related citations
Per page 10 20 50 100 | Total 7933
Authors Title Published Journal PubMed Link
Frégeau CJ et al. Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate. 1992 Nucleic Acids Res. pmid:1620608
Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. 1995 Nucleic Acids Res. pmid:7899083
Cotten M and Chalkley R Hyperacetylated histones facilitate chromatin assembly in vitro. 1985 Nucleic Acids Res. pmid:2582355
Naranjo JR et al. Unusual c-fos induction upon chromaffin PC12 differentiation by sodium butyrate: loss of fos autoregulatory function. 1990 Nucleic Acids Res. pmid:2114014
Andrews GK and Adamson ED Butyrate selectively activates the metallothionein gene in teratocarcinoma cells and induces hypersensitivity to metal induction. 1987 Nucleic Acids Res. pmid:3601676
Loidl P et al. RNA polymerase activity and template activity of chromatin after butyrate induced hyperacetylation of histones in Physarum. 1984 Nucleic Acids Res. pmid:6462909
Goldstein S et al. Enhanced transfection efficiency and improved cell survival after electroporation of G2/M-synchronized cells and treatment with sodium butyrate. 1989 Nucleic Acids Res. pmid:2786626
Kress H et al. Butyrate induced accumulation of a 2.3 kb polyadenylated H1(0) histone mRNA in HeLa cells. 1986 Nucleic Acids Res. pmid:3020508
Gorman CM et al. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. 1983 Nucleic Acids Res. pmid:6316266
Perry CA and Annunziato AT Influence of histone acetylation on the solubility, H1 content and DNase I sensitivity of newly assembled chromatin. 1989 Nucleic Acids Res. pmid:2740216
Oliva R et al. Histone hyperacetylation can induce unfolding of the nucleosome core particle. 1990 Nucleic Acids Res. pmid:2339060
Ferenz CR and Nelson DA N-Butyrate incubation of immature chicken erythrocytes preferentially enhances the solubility of beta A chromatin. 1985 Nucleic Acids Res. pmid:4000950
Birren BW and Herschman HR Regulation of the rat metallothionein-I gene by sodium butyrate. 1986 Nucleic Acids Res. pmid:2868444
Reeves R et al. Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. 1985 Nucleic Acids Res. pmid:3859838
Brotherton TW et al. Only a small fraction of avian erythrocyte histone is involved in ongoing acetylation. 1981 Nucleic Acids Res. pmid:7312625
Basuli F et al. Synthesis of ApoSense compound [18F]2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid ([18F]NST732) by nucleophilic ring opening of an aziridine precursor. 2012 Nucl. Med. Biol. pmid:22336374
Chattopadhyay S et al. Purification and stabilization of 99mTc-d,l-HMPAO: role of organic extractants. 2001 Nucl. Med. Biol. pmid:11518658
Kim SW et al. Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. 2013 Nucl. Med. Biol. pmid:23906667
Zhou X et al. The feasibility of using a baculovirus vector to deliver the sodium-iodide symporter gene as a reporter. 2010 Nucl. Med. Biol. pmid:20346869
Vicent GP et al. Erk signaling and chromatin remodeling in MMTV promoter activation by progestins. 2009 Nucl Recept Signal pmid:20087429
Wang L and Tsai CC Atrophin proteins: an overview of a new class of nuclear receptor corepressors. 2008 Nucl Recept Signal pmid:19043594
Guo R et al. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells. 2010 Nucl Med Commun pmid:20683361
Monleón D et al. Metabolite profiling of fecal water extracts from human colorectal cancer. 2009 NMR Biomed pmid:19006102
de Graaf AA et al. Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMR. 2010 NMR Biomed pmid:19593762
Jacobs DM et al. (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. 2008 NMR Biomed pmid:18085514
Kameyama T et al. [Behavioral pharmacological action of Ca-4-(3,5-dihydroxy-3-methylpenthylamido) butyrate (mevalonic GABA, MV-GABA)]. 1987 Nippon Yakurigaku Zasshi pmid:3034749
Ochiai K and Kurita-Ochiai T [Alternative effects of a metabolic by-product, butyric acid, produced by oral anaerobes]. 2014 Nippon Yakurigaku Zasshi pmid:25109521
Maruo T et al. Discordant induction of tumor-associated antigen, TA-4 and chorionic gonadotropin beta in cultured cervical carcinoma cells. 1987 Nippon Sanka Fujinka Gakkai Zasshi pmid:3493311
Kakizoe H and Ninagawa T [The development of enzyme immunoassay for prostaglandin F2 alpha]. 1987 Nippon Sanka Fujinka Gakkai Zasshi pmid:3546538
Suzuki M et al. [Production of CA125 in cell lines derived from human ovarian carcinoma: in relation to the cell cycle]. 1992 Nippon Sanka Fujinka Gakkai Zasshi pmid:1506733
Nozawa S et al. [Modulation of alkaline phosphatase by butyrate and prednisolone in uterine cervical cancer cell line (SKG-III)]. 1984 Nippon Sanka Fujinka Gakkai Zasshi pmid:6699450
Saito S et al. [Quenching effect and analysis of cell proliferation in dual-laser flow cytometry with human endometrial adenocarcinoma cells in vitro]. 1990 Nippon Sanka Fujinka Gakkai Zasshi pmid:2332670
Kaiho T et al. [Effects of various agents on the proliferation and hCG secretion of choriocarcinoma cells in vitro]. 1984 Nippon Sanka Fujinka Gakkai Zasshi pmid:6094687
Nozawa S et al. HCG production of non-trophoblastic cancer cell lines and its modulation by sodium butyrate. 1985 Nippon Sanka Fujinka Gakkai Zasshi pmid:4056538
Hamasaki Y et al. Butyric acid enhances cyclooxygenase activity in rat basophilic leukemia 2H3 cells. 1988 Nippon Ketsueki Gakkai Zasshi pmid:3144111
Nakamaki T et al. UV-induced DNA repair in leukemic cell differentiation. 1989 Nippon Ketsueki Gakkai Zasshi pmid:2588962
Furukawa M et al. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate]. 1989 Nippon Jibiinkoka Gakkai Kaiho pmid:2545850
Yamazaki H [Induction of differentiation in testicular choriocarcinoma cells and its role in cancer therapy]. 1989 Nippon Hinyokika Gakkai Zasshi pmid:2556605
Niki S et al. [A case of hepatocellular carcinoma associated with autoimmune hepatitis and increased scintigraphy of liver accumulation]. 1997 Nihon Shokakibyo Gakkai Zasshi pmid:9095644
Ohwaki K [High carboxylic acid level in the gingival crevicular fluid (GCF) of the patients with advanced periodontal disease]. 1988 Nihon Shishubyo Gakkai Kaishi pmid:3078007
Saito S et al. [The relationship between changes of the steroid receptor and synchronization in human adenocarcinoma cells in vitro of the endometrium]. 1985 Nihon Naibunpi Gakkai Zasshi pmid:2417895
Seto K et al. [Relationship between butyrate metabolism and TCA cycle in liver slices of normal, starved and alloxan diabetic sheep]. 1974 Nihon Naibunpi Gakkai Zasshi pmid:4859080
Nakano K et al. [A novel approach for cancer chemoprevention referred to as "gene-regulating chemoprevention"]. 1998 Nihon Geka Gakkai Zasshi pmid:9695075
Wei J et al. Ecological trade-offs between jasmonic acid-dependent direct and indirect plant defences in tritrophic interactions. 2011 New Phytol. pmid:21039561
Gudesblat GE et al. Guard cell-specific inhibition of Arabidopsis MPK3 expression causes abnormal stomatal responses to abscisic acid and hydrogen peroxide. 2007 New Phytol. pmid:17286820
Sasajima H et al. Intranasal administration of rotenone in mice attenuated olfactory functions through the lesion of dopaminergic neurons in the olfactory bulb. 2015 Neurotoxicology pmid:26493152
Johnson J et al. Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice. 2018 Neurotoxicology pmid:28610743
Wang P et al. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. 2013 Neurotoxicology pmid:23558232
Ebert PS and Salcman M Differentiation therapy is potentiated by chemotherapy and hyperthermia in human and canine brain tumor cells in vitro. 1994 Neurosurgery pmid:8008163
Ito N et al. Inhibitory effects of sodium butyrate on proliferation and invasiveness of human glioma cells. 2001 Neurosurgery pmid:11504120
Cargioli TG et al. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. 2007 Neurosurgery pmid:17415213
Engelhard HH et al. Therapeutic effects of sodium butyrate on glioma cells in vitro and in the rat C6 glioma model. 2001 Neurosurgery pmid:11270553
Engelhard HH et al. Molecular characterization of glioblastoma cell differentiation. 1997 Neurosurgery pmid:9316051
Shen HY et al. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice. 2008 Neuroscience pmid:18848971
Ferland CL and Schrader LA Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins. 2011 Neuroscience pmid:21056634
Chen PS et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. 2007 Neuroscience pmid:17850978
St Laurent R et al. Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease. 2013 Neuroscience pmid:23623990
Dash PK et al. Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. 2009 Neuroscience pmid:19531374
Zhang ZZ et al. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush. 2012 Neuroscience pmid:22867974
Silva PF et al. Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated by sodium butyrate. 2012 Neuroscience pmid:22067609
Albuquerque Filho MO et al. Dual influences of early-life maternal deprivation on histone deacetylase activity and recognition memory in rats. 2017 Neuroscience pmid:28089578
Singh V et al. Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia. 2014 Neuroscience pmid:24480366
Zielke HR et al. Synthesis of glutamate and glutamine in dibutyryl cyclic AMP-treated astrocytes. 1989 Neurosci. Lett. pmid:2563906
Kume T et al. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. 2008 Neurosci. Lett. pmid:18691633
Tixier E et al. Acidity induces c-Fos expression in a subpopulation of human colonic submucosal neurons. 2006 Neurosci. Lett. pmid:16828227
Sun J et al. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress. 2016 Neurosci. Lett. pmid:26957230
Ajamian F et al. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells. 2004 Neurosci. Lett. pmid:15234474
Redmond AJ et al. Selective activation of the A10, but not A9, dopamine neurons in the rat by the predator odor, 2,5-dihydro-2,4,5-trimethylthiazoline. 2002 Neurosci. Lett. pmid:12147308
Steckert AV et al. Effects of sodium butyrate on aversive memory in rats submitted to sepsis. 2015 Neurosci. Lett. pmid:25888815
Blank M et al. Enhancement of memory consolidation by the histone deacetylase inhibitor sodium butyrate in aged rats. 2015 Neurosci. Lett. pmid:25837444
Wang C et al. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes. 2011 Neurosci. Lett. pmid:21543053
Beattie DT et al. Baclofen antagonism by 4-amino-3-(5-methoxybenzo[b]furan-2-yl) butanoic acid in the cat spinal cord. 1989 Neurosci. Lett. pmid:2761779
Febo M et al. Cocaine-induced metabolic activation in cortico-limbic circuitry is increased after exposure to the histone deacetylase inhibitor, sodium butyrate. 2009 Neurosci. Lett. pmid:19638299
Sun J et al. The effects of sodium butyrate, an inhibitor of histone deacetylase, on the cocaine- and sucrose-maintained self-administration in rats. 2008 Neurosci. Lett. pmid:18599214
Heinrichs SC et al. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions. 2013 Neurosci. Lett. pmid:23916657
Jing L et al. Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. 2011 Neurosci. Lett. pmid:21396430
Fukamauchi F et al. Differential effects of butyrate and dibutyryl cAMP on mRNA levels of muscarinic acetylcholine receptor subtypes expressed in neurohybrid cell lines. 1996 Neurosci. Lett. pmid:8823760
Ou HC et al. Sodium butyrate decreases histamine-stimulated calcium mobilization in C6 glioma cells. 1997 Neuroreport pmid:9172138
Wang J et al. Efficient transduction of spiral ganglion neurons in vitro by baculovirus vectors. 2007 Neuroreport pmid:17762707
Zia MT et al. Role of Ca2+ in induction of neurotransmitter-related gene expression by butyrate. 2004 Neuroreport pmid:15129169
Núñez-Jaramillo L et al. Sodium butyrate into the insular cortex during conditioned taste-aversion acquisition delays aversive taste memory extinction. 2014 Neuroreport pmid:24323127
Kilgore M et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. 2010 Neuropsychopharmacology pmid:20010553
Hebb AL et al. Odor-induced variation in anxiety-like behavior in mice is associated with discrete and differential effects on mesocorticolimbic cholecystokinin mRNA expression. 2002 Neuropsychopharmacology pmid:12431849
Sanchis-Segura C et al. Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. 2009 Neuropsychopharmacology pmid:19727068
Intlekofer KA et al. Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism. 2013 Neuropsychopharmacology pmid:23615664
Sarkar A et al. Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior. 2014 Neuropsychopharmacology pmid:24663010
Schroeder FA et al. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. 2008 Neuropsychopharmacology pmid:18288092
Maloney AE and Sikich L Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. 2010 Neuropsychiatr Dis Treat pmid:21127693
Pennick M Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. 2010 Neuropsychiatr Dis Treat pmid:20628632
Bushell TJ et al. Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4. 1995 Neuropharmacology pmid:7617150
Kratsman N et al. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model. 2016 Neuropharmacology pmid:26577018
Rane P et al. The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. 2012 Neuropharmacology pmid:22353286
Pascual M et al. Changes in histone acetylation in the prefrontal cortex of ethanol-exposed adolescent rats are associated with ethanol-induced place conditioning. 2012 Neuropharmacology pmid:22349397
Marinova Z et al. Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons. 2011 Neuropharmacology pmid:20888352
Gerace E et al. Interplay between histone acetylation/deacetylation and poly(ADP-ribosyl)ation in the development of ischemic tolerance in vitro. 2015 Neuropharmacology pmid:25623965
Green AL et al. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. 2017 Neuropharmacology pmid:28743636
Klein C et al. Pharmacological doses of gamma-hydroxybutyrate (GHB) potentiate histone acetylation in the rat brain by histone deacetylase inhibition. 2009 Neuropharmacology pmid:19427877
Gundersen BB and Blendy JA Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. 2009 Neuropharmacology pmid:19393671
Han A et al. Possible additional antidepressant-like mechanism of sodium butyrate: targeting the hippocampus. 2014 Neuropharmacology pmid:24607816
Gagliano H et al. High doses of the histone deacetylase inhibitor sodium butyrate trigger a stress-like response. 2014 Neuropharmacology pmid:24212060